Protein energy malnutrition increases arginase activity in monocytes and macrophages. by Corware, K. et al.
Corware et al. Nutrition & Metabolism 2014, 11:51
http://www.nutritionandmetabolism.com/content/11/1/51RESEARCH Open AccessProtein energy malnutrition increases arginase
activity in monocytes and macrophages
Karina Corware1, Vanessa Yardley2, Christopher Mack1, Steffen Schuster3, Hafid Al-Hassi1, Shanthi Herath4,
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Background: Protein energy malnutrition is commonly associated with immune dysfunctions and is a major factor
in susceptibility to infectious diseases.
Methods: In this study, we evaluated the impact of protein energy malnutrition on the capacity of monocytes and
macrophages to upregulate arginase, an enzyme associated with immunosuppression and increased pathogen
replication.
Results: Our results show that monocytes and macrophages are significantly increased in the bone marrow and
blood of mice fed on a protein low diet. No alteration in the capacity of bone marrow derived macrophages
isolated from malnourished mice to phagocytose particles, to produce the microbicidal molecule nitric oxide and
to kill intracellular Leishmania parasites was detected. However, macrophages and monocytes from malnourished mice
express significantly more arginase both in vitro and in vivo. Using an experimental model of visceral leishmaniasis, we
show that following protein energy malnutrition, the increased parasite burden measured in the spleen of these mice
coincided with increased arginase activity and that macrophages provide a more permissive environment for parasite
growth.
Conclusions: Taken together, these results identify a novel mechanism in protein energy malnutrition that might
contributes to increased susceptibility to infectious diseases by upregulating arginase activity in myeloid cells.
Keywords: Arginase, Macrophages, Monocytes, Nitric oxide, LeishmaniasisBackground
Undernutrition results from insufficient dietary intake,
poor absorption and/or inadequate use of the nutrients
consumed. It is a major health concern, mainly through-
out the developing world and children are especially
affected. An estimated 826 million people in the world
are undernourished, of those 95.9% are in the develop-
ing world [1]; 178 million children under the age of 5
are stunted and 55 million are wasted [2]. In 2011, 6.9
million children under 5 years died, one third of these
deaths were related to increased susceptibility to infec-
tions due to undernutrition [2]. Protein energy malnu-
trition (PEM) is thought to be one of the major causes
of immunodeficiency. PEM and infection have always* Correspondence: p.kropf@imperial.ac.uk
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unless otherwise stated.been closely associated, as PEM is a common cause of
susceptibility to infections. Undernutrition in children
negatively impacts on thymic development, therefore
compromising immune responses [3]. In malnourished
patients, both innate and acquired immunity are affected
[4,5] and common immune defects are an imbalance in
the ratio of CD4/CD8+ T cells [6], low expression levels of
CD69 on lymphocytes [7], biased T helper cell responses
[8], reduced antibody responses [6]; impaired phagocytosis
by macrophages [9,10], lower nitrite/nitrate concen-
trations in wound fluid [11] and decreased NF-kappaB
activation by macrophages [12] have also been shown
in experimental models of PEM.
Arginase, an enzyme that catalyses the conversion of
L-arginine, can be upregulated in murine macrophages,
dendritic cells and neutrophils [13], however, humanl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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[13]). There are two isoforms of arginase in mammals,
arginase I and arginase II [14,15]. The catabolism of
L-arginine by arginase can regulate the availability of
L-arginine and therefore the efficiency of T cell responses:
increased catabolism of L-arginine by arginase results in
the depletion of L-arginine from the microenvironment;
since L-arginine is essential for efficient T cell activation,
this decrease in L-arginine results in impaired T cell
responses [13,16-18]. In addition, the catabolism of
L-arginine by arginase results in the production of
ornithine, which is further catabolised into polyamines
that are crucial for cell division; and into proline, which
is the building block for collagen synthesis. L-arginine
is also the substrate for nitric oxide synthase (NOS),
that catabolises L-arginine into nitric oxide (NO), a
molecule critical for the regulation of vascular homeo-
stasis, neurotransmission and the killing of many path-
ogens [19]. Therefore, by competing for the shared
substrate L-arginine, increased arginase activity also
modulates the production of NO. Consequently, defi-
ciencies in L-arginine metabolism can disrupt many
cellular and organ functions.
Increased arginase activity is common to several
pathological and physiological conditions: it has been
prominently described in cancer [16,18], but also in
asthma, myocardial infarction, pregnancy and infec-
tious and autoimmune diseases (summarised in [13]).
We have recently shown that increased arginase activity is
a marker of disease severity in HIV seropositive (HIV+)
patients [20], in patients with visceral leishmaniasis and
HIV co-infection [21] and in patients with visceral [22]
and cutaneous [23] leishmaniasis. Malnutrition is a major
contributor to both progression and severity of visceral
leishmaniasis (VL) and several studies in the mouse
have shown that PEM and micronutrient deficient diet
exacerbates VL [24].
Nutrition has been shown to impact on the pheno-
type of macrophages: in obesity, adipose tissue is char-
acterized by infiltration of inflammatory macrophages,
in contrast to lean adipose tissue, where a majority of
anti-inflammatory macrophages are present [25]. In the
present study, we tested the hypothesis that malnutrition
impacts on macrophage effector functions and results in
increased arginase activity, therefore contributing to
increased susceptibility to disease.
Methods
Mice
Specific pathogen free female BALB/c mice (18 g) were
purchased from Charles River (UK) and were kept in indi-
vidually vented cages. The animal colonies were screened
regularly for mouse pathogens and consistently tested
negative.Ethics statement
Animal experiments were performed in accordance with
home office and institutional guidelines. The project
licence (PPL 70/6712) was approved by the Imperial
College Central Animal Welfare & review Body (AWERB)
committee.
Mice were fed on the different diets following a 3-day
period of acclimatisation. Control mice were fed a diet
consisting of 14.4% protein, 61.7% carbohydrates and
2.7% fat (RM1, Harlem Laboratories Inc, Madison,
Additional file 1). The group of mice that was malnour-
ished (MN group) was fed a diet consisting of 0.7% protein,
87.0% carbohydrates and 4.1% fat (Modification of
TestDiet AIN-93 M w/No protein, TestDiet, Additional
file 2). Both diets had similar amounts of calories: control
group =3.5 kcal/g and MN group: 3.85 kcal/g and both
groups of mice had ad libitum access to food and water.
Sample collection
Bone marrow cells were obtained by flushing the
femurs of BALB/c mice and precursor cells were used
immediately for flow cytometry or were frozen in PBS
containing 1% protease inhibitor cocktail (Sigma) for
the determination of arginase activity. To obtain bone
marrow derived macrophages (BMMΦ), fresh precursor
cells were cultured for 8 days in a humid atmosphere at
37°C and 10% CO2 in hydrophobic Teflon bags in DMEM
(Sigma) containing 10% heat-inactivated FCS (Gibco), 5%
horse serum (Gibco), the supernatant of L929 fibroblasts
at a final concentration of 15% (v/v) as a source of colony
stimulating factor (CSF), 50 IU/ml penicillin, 50 μg/ml
streptomycin, and 292 μg/ml L-glutamine (Sigma) as
described in [26]. To obtain bone marrow-derived
neutrophils, fresh precursor cells were cultured for
7 days as described in [27].
Peripheral blood mononuclear cells (PBMCs): blood
was collected in EDTA tubes by cardiac puncture and
PBMCs were isolated by density gradient centrifuga-
tion on Histopaque-1077 (Sigma). Before harvesting
the interphase, the plasma was collected and frozen for
further analysis. Cells were washed in phosphate buff-
ered saline (PBS) and were used immediately for flow
cytometry or were frozen in PBS containing 1% prote-
ase inhibitor cocktail (Sigma) for the determination of
arginase activity.
Spleen cells: spleens from BALB/c mice were homo-
genised in PBS and red cells were lysed with red cell
lysis buffer as described in [27] and were frozen in PBS
containing 1% protease inhibitor cocktail (Sigma) for
the determination of arginase activity.
Macrophage activation
Mature BMMΦ and mature BM-derived neutrophils
were harvested and 5 × 105 BMMΦ/ml were plated in
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(Gibco), 50 IU/ml penicillin, 50 μg/ml streptomycin,
and 292 μg/ml L-glutamine (Sigma) and 5 × 10−5 M 2-
mercaptoethanol (Sigma). BMMΦ were stimulated with
20U/ml IL-4 or with 100U/ml IFN-γ and 500U/ml TNF-α
(Peprotech) or with 1 μg LPS (Sigma) for 72 hours,
unstimulated macrophages were used as control. Mature
BM-derived neutrophils were stimulated with 20U/ml
IL-4 (Peprotech) and unstimulated mature BM-derived
neutrophils were used as control.
Phagocytosis assay
Mature BMMΦ (1 × 105 BMMΦ) were incubated for
1 hour with pHrodo™ Bioparticles® fluorescent particles
according to the manufacturer’s protocol (Molecular
Probes). Analysis of the mean fluorescence intensities
(MFI) was performed on a LSRII (BD Bioscience) and
results were analyzed using Summit v4.3 software.
Flow cytometry
Antibodies used were as follows: anti-Ly-6C (clone HK1.4,
eBioscience), anti-Ly-6G (clone RB6-8C5, eBioscience),
anti-F4/80 (clone BM8, BD Biosciences), anti-arginase I
(Polyclonal sheep IgG, R&D). Cells were washed with PBS,
the fixation step was performed with 2% formaldehyde in
PBS and the permeabilisation step with 0.5% saponin in
PBS. Analysis was performed on a LSRII (BD Bioscience)
and results were analyzed using Summit v4.3 software.
The percentages of positive cells with the isotype
controls were <1%.
Determination of nitrite and arginase activity
NO2- accumulated in the supernatant was used as an
indicator of NO production and measured using the Griess
reagent as described in [28]. Culture supernatants were
collected after 48 h, and equal volumes of macrophage cul-
ture supernatants and Griess reagent (1% sulphanilamide/
0.1% N-(1-naphthyl)ethylenediamine dihydrochloride/2.5%
H3PO4) were mixed and incubated for 10 min at room
temperature. Absorbance was measured at 540 nm. Nitrite
concentration was determined using NaNO2 as standard.
The enzymatic activity of arginase was measured as
previously described [29]. Briefly, the cell lysate was acti-
vated by heating for 10 min at 56°C. L-arginine hydrolysis
was conducted by incubating the activated lysate with
0.5 M L-arginine (pH 9.7) at 37°C for 15 to 120 minutes.
The reaction was stopped with H2SO4(96%)/H3PO4(85%)/
H2O (1:3:7, v/v/v, VWR). α-isonitrosopropiophenone (ISPF,
dissolved in 100% ethanol, Sigma) was added and incu-
bated for 45 min at 100°C, followed by 30 min at 4°C. A
standard curve was obtained by treating serially diluted
urea with ISPF and incubated in the final step. The optical
density (OD) was measured at 550 nm.Protein concentration of samples was measured using
the BCA Protein Assay kit (Pierce) as previously described
[29]. One unit of enzyme activity is defined as the amount
of enzyme that catalyzes the formation of 1 μmol of urea
per min.
Determination of L-arginine and L-ornithine
concentrations
The concentration of L-arginine and L-ornithine in plasma
were measured by ion exchange chromatography and
quantified by post-column ninhydrin derivatisation using
an amino acid analyser (AminoTac JLC- 500/V) as
described previously [30].
Infection of mice and macrophages with Leishmania
infantum
Mice
Leishmania (L) infantum amastigotes (MHOM/MA/67/
ITMPA263 (MON-1) were derived from infected RAG1.
B6 mice. BALB/c mice were infected 7 days after start of
the experiment with 3 × 106 amastigotes in the lateral
tail vein and were culled 9 days later. Spleen cells were
isolated as described above and 5 × 106 cells were resus-
pended in 1 ml M199 containing 50 IU/ml penicillin,
50 μg/ml streptomycin, and 292 μg/ml L-glutamine
(Sigma), 2% hepes and 4 μM sodium bicarbonate (Sigma)
and 10% fetal bovine serum (Gibco) and incubated in a
humid atmosphere at 26°C and 5% CO2. Eight days later,
the wells were resuspended carefully and the transformed
promastigotes were fixed with PBS containing 2% formal-
dehyde and counted using a haemocytometer.
Macrophages
5 × 105 BMMΦ/ml cells were plated and stimulated with
20U/ml IL-4 or with 100U/ml IFN-γ and 500U/ml TNF-α
(Peprotech). Unstimulated macrophages were used as
control. Four hours later, the cultures were infected with
25 × 105/ml L. infantum promastigotes. After 96 h, the
macrophages were washed and lysed with HEPES-buffered
medium containing 0.008% SDS [31] and 1 ml of complete
M199 was added to each well, incubated and the trans-
formed promastigotes were counted as described above.
Statistical analyses
Data were evaluated for statistical differences using
a two-tailed Mann–Whitney test (GraphPad Prism 5)
and differences were considered statistically significant
at p <0.05. Results are expressed as mean with 95% CI.
Results
Impact of protein energy malnutrition on weight loss
We first set up a model of malnutrition in mice to test
the impact of PEM, using an isocaloric diet containing
0.7% protein. As shown in Figure 1, mice fed on the low
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Figure 1 Weight loss in mice fed on a low protein diet.
Groups of BALB/c (n =5) mice were fed with a low protein diet
(=malnourished (MN) group, 0.7% protein) or normal diet (=control
group, 14.4% protein) for 16 days. Their weight was measured at
regular intervals. Data show the results of one representative
experiment out of five independent experiments. Results are
expressed as mean with 95% CI.
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had lost an average of 26.5% of their initial weight, whereas
the control mice fed on a 13.8% diet gained weight. Mice
fed on the low calorie diet ate 2.53 g/mouse/day and mice
fed on a 13.8% diet ate 3.01 g /mouse/day.
Impact of malnutrition on the frequency of monocytes in
the bone marrow and peripheral blood mononuclear cells
Next we studied the impact of malnutrition on monocytes.
Since Ly6C + bone marrow monocytes are released into
the peripheral blood [32], we assessed their frequency in
bone marrow (BM) and peripheral blood by flow cytome-
try. Results presented in Figure 2A show a significant
increase in the frequency of Ly6Chigh monocytes in the
BM isolated from malnourished (MN) mice (p =0.0286).
We then measured the frequency of F4/80+ monocytes in
the PBMCs from both groups of mice and detected a
significant increase in the frequency of F4/80+ monocytes
in the MN group (p = 0.0286, Figure 2B). As previously
described [33], the majority (>91%, data not shown) of the
blood monocytes express low levels of Ly6C. Interestingly,
the frequency of inflammatory F4/80 + Ly6C + cells was
significantly higher in the blood of MN mice (p =0.0286,
Figure 2C).
These results show that in MN mice, the frequencies of
Ly6C +monocytes and F4/80+ monocytes are increased in
BM and PBMCs, respectively.
Impact of malnutrition on macrophage effector functions
in vitro
Next we differentiated bone marrow cells from both
groups of mice into mature BMMΦ and assessed their
effector functions. Following 8 days of differentiation inconditioning medium, the number of F4/80+ cells was
similar in both groups (p =0.4857, data not illustrated).
We measured the capacity of these cells to phagocytose
BioParticles and the results in Figure 3A show that
BMMΦ derived from control and MN mice have a simi-
lar capacity to phagocytose, as the MFIs of the interna-
lised fluorescent particles were comparable (p =0.4857).
We then compared the capacity of BMMΦ derived from
control and MN mice to produce nitric oxide (NO) and
upregulate arginase. As shown in Figure 3B, BMMΦ
from both groups of mice produce similar levels of NO
when stimulated with IFN-γ and TNF-α (p =0.2000) or
with LPS (p =0.8939). Unstimulated BMMΦ and
BMMΦ stimulated with IL-4 did not produce detectable
levels of NO (Figure 3B). Next, we measured the
capacity of BMMΦ to upregulate arginase; results
presented in Figure 3C show that in response to IL-4,
BMMΦ derived from MN mice express significantly
increased arginase activity (p =0.0286). Similarly, follow-
ing stimulation with LPS, arginase activity was signifi-
cantly higher in BMMΦ derived from MN mice
(p =0.0286, Figure 3C). The capacity of bone marrow-
derived neutrophils to upregulate arginase in response
to IL-4 was similar in both groups (26.3 vs 28.53 mU/mg
protein, p =0.4857).
These results show that whereas the production of
NO is similar in both groups of mice, activation of
BMMΦ derived from MN mice with IL-4 or LPS results
in increased arginase activity.
Impact of malnutrition on macrophage effector functions
in vivo
The results presented in Figure 3C show that BMMΦ
from MN mice have the capacity to express higher argi-
nase activity than those from control mice. To deter-
mine whether arginase was also increased in vivo in
mice fed on a low protein diet, we measured the levels
of arginase activity in PBMCs. As shown in Figure 4A,
the levels of arginase activity were significantly higher in
PBMCs from malnourished mice (p =0.0298). Next the
phenotype of arginase + cells was identified by flow
cytometry. As shown in Figures 4B, the large majority of
arginase-1 positive cells are F4/80+ in the PBMCs, and
we have previously showed that arginase 1, but not
arginase 2, is upregulated in F4/80+ cells [26]. These
cells were Ly6G negative, therefore excluding neutrophils
(data not shown), In the PBMCs from MN mice, the per-
centage of F4/80 + arginase + cells (p =0.0286, Figure 4C)
and the MFI of arginase (p =0.0421, Figure 4D) were also
significantly increased as compared to controls. Next, we
determined whether increased levels of arginase activity in
the PBMCs coincide with lower levels of L-arginine [30]:
our results show that the levels of L-arginine are
significantly lower in the plasma of MN mice (65.5 μM
AB C
Figure 2 Percentages of monocytes in the bone marrow and peripheral blood mononuclear cells. The percentages of Ly6C + cells in BM
(A), F4/80+ (B) and F4/80 + Ly6C + cells (C) in the PBMCs were determined by flow cytometry in cells isolated from mice fed on a low protein
(MN, n =4) or normal (control, n =4) diet for 16 days. Data show the results of one representative experiment out of three independent experiments.
*: p <0.05. Results are expressed as mean with 95% CI.
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agreement with these results, the levels of L-ornithine,
one of the products of arginase-mediated L-arginine
catabolism, were increased (MN: 121.3 vs controls:
89.5, p =0.0286, data not illustrated).
Arginase activity was also significantly higher in the
bone marrow (p =0.0286, Figure 4E), but the phenotype
of arginase + cells was not identified because the fre-
quencies of arginase + cells were too low.
Impact of malnutrition on disease development in
Leishmania infantum-infected mice
We have previously showed that increased arginase corre-
lates with increased parasite replication and that competi-
tive inhibition of arginase resulted in reduced parasite
growth [26,30]. Here we determined whether the increased
arginase activities observed in mice fed with a low protein
diet did coincide with increased parasite load. Seven days
after the start of the diets, mice were infected i.v. with
Leishmania (L). infantum and 8 days later, parasite load
and arginase activities were measured in the spleen. As
shown in Figure 5A, the increased parasite load in the
spleen of MN mice (p =0.0286) coincided with increased
arginase activity (p =0.0286, Figure 5B).
In macrophages, efficient parasite replication is controlled
at least in part by arginase: catabolism of L-arginine byarginase results in the production of polyamines that
the parasites use for their replication; competitive inhib-
ition of arginase reduced the production of polyamines in
BMMΦ activated with IL-4 and thereby clearly reduced
parasite replication [26]. Since BMMΦ derived from MN
mice express more arginase, we assessed whether this pro-
vides a more permissive environment for parasite growth;
we activated BMMΦ with IL-4 and infected them with
L. infantum and measured their growth as well as arginase
activity; unstimulated macrophages as well as macro-
phages stimulated with IFN-γ and TNF-α were used as
controls. As shown in Figure 5C, L. infantum grew signifi-
cantly better in IL-4-stimulated BMMΦ derived from MN
mice (p =0.0286), and this increase in parasite burden
coincided with increased arginase activity (p =0.0286,
Figure 5D). As shown previously [26], no parasites could
be detected in BMMΦ activated with IFN-γ and TNF-α;
no significant difference was observed in parasite growth
in unstimulated BMMΦ derived from MN and control
mice (p =0.6857, Figure 5C).
The results presented in Figure 5 show that L. infan-
tum-infected mice on a low protein diet have a signifi-
cantly higher parasite burden paralleled by significantly
increased arginase activity, which provides a more per-
missive environment in host macrophages for parasite
growth.
A B
C
Figure 3 Bone marrow derived macrophage effector functions. Bone marrow cells were isolated from the bone marrow from mice fed on a
low protein (MN, n =4) or normal (control, n =4) diet for 16 day and were differentiated in conditioning medium. Eight days later, the capacity of
these cells to phagocytose particles was determined by flow cytometry (A). In addition, BMMΦ were activated with IL-4, IFN-γ and TNF-α, LPS or
left unactivated (nil) and the production of nitric oxide (B) and the activity of arginase (C) were measured as described in material and methods.
Data show the results of one representative experiment out of four independent experiments. *: p <0.05. Box = interquartile range and median;
whiskers = range. nd = not detectable.
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PEM is one of the major causes of immunosuppression,
modifying both innate and adaptive immunity. It is highly
prevalent in low-income countries, particularly in children
[4]. In the developed world, PEM is also a serious health
concern, mainly seen in the elderly, with up to 10% of
older people undernourished in nursing homes and up to
50% of older people undernourished when discharged
from hospital [34]. Malnutrition is associated with a
plethora of problems, such as fatigue, anaemia, cogni-
tive abnormalities, immune dysfunctions and increased
susceptibility to infections [34]. Monocytes and macro-
phages play a major role in the elimination of patho-
gens. Here we show that the frequency of monocytes is
increased in the bone marrow and PBMCs of MN mice,
suggesting a dysregulation in the haematopoiesis in these
mice. This is in agreement with a study by Borelli et al.
[35] that showed a 2.5-fold increase in the number of
peripheral blood monocytes. Whereas macrophages and
monocytes can be instructed to kill intracellular pathogens,
they can also act as “safe target”. Indeed, in Leishmania
major infected nonhealing mice, macrophage-granulocytes
precursor cells were shown to be dramatically increased
during infection, thereby offering a large number of hostcells for the parasites to infect [36,37]. Since these cells
have not yet developed their full microbicidal potential
[37], the parasites cannot be killed efficiently and the
myeloid cells represent therefore a more permissive
environment for the parasites to survive. We also showed
an increase in the frequency of F4/80 + Ly6C + inflamma-
tory macrophages in the blood of MN mice; these macro-
phages have been shown to be rapidly recruited to sites
of inflammation. Since malnutrition has been associated
with chronic inflammation [38], this might explain the
increased frequency of these macrophages during PEM.
Whereas we detected arginase activity in the BM cells,
we were not able to able to identify the phenotype of
arginase-expressing cells. Since other cells than macro-
phages have been shown to express arginase, it is possible
that cells such as dendritic cells, neutrophils [27,28] or
innate lymphoid cells [39] might contribute.
Here, we showed that PEM did not impact on the cap-
acity of BMMΦ to produce NO in response to activation
with IFN-γ and TNF-α or LPS; nor on the capacity of
BMMΦ capacity to kill intracellular Leishmania para-
sites. We also showed that in vitro, bone marrow cells
from malnourished mice did proliferate and differentiate
similarly to those from control mice as both the number
A B
C D E
Figure 4 Arginase activity ex vivo. Arginase activity was measured by enzymatic assay in PBMCs (A) and bone marrow cells ex vivo (E). The
phenotype (B) and percentage (C) of arginase expressing and the MFI of arginase (D) was determined by flow cytometry. Bone marrow cells
were isolated from 4 mice and pooled, and PBMCs were isolated from the peripheral blood from 4 mice and pooled. Data show the results of
one representative experiment out of four independent experiments. *: p <0.05. Box = interquartile range and median; whiskers = range.
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thermore, phagocytosis of bioparticles was not impaired
in BMMΦ derived from malnourished mice. In contrast, it
has been previously shown that some macrophage func-
tions are altered during PEM: the phagocytic capacity and
production of superoxide anions, indicative of their micro-
bicidal competence, were shown to be impaired [10,40,41],
suggesting that increased susceptibility to disease might
be due to an impaired capacity of phagocytic cells to kill
pathogens. The discrepancies between these studies and
ours could be due to the different macrophages used:
BMMΦ in our study versus elicited peritoneal exudate
macrophages in the other studies [10,40,41]. Macro-
phages derived from different compartments such as
bone marrow, spleen or peritoneum have different
capacities to phagocytose dextran beads [42]. It is also
possible that the different diets used, characterised by
differences in calories, fat, micronutrient and protein
contents, also impact on macrophage effector functions.
We have previously shown that bone marrow derived
macrophages from younger mice express significantly higherlevels of arginase 1 than aged mice and promote parasite
growth more efficiently [43]. Furthermore, L. major-infected
younger mice develop exacerbated lesion pathology and
higher parasite burdens than aged mice [43]. A previous
study from 1984 showed that arginase was decreased in the
saliva of children with different grades of PEM [44]. We
have previously compared the levels of arginase activity in
the saliva of severely malnourished patients with visceral
leishmaniasis and severely malnourished patients with
visceral leishmaniasis and HIV co-infection and did not find
significant differences or correlation between the levels of
malnutrition and the levels of arginase activity [21]; nor did
we find differences when compared to healthy controls
(P. Kropf, unpublished data).
Our results show that BMMΦ derived from malnour-
ished mice express significantly more arginase in response
to IL-4 or LPS, and we also measured considerably more
arginase activity in the bone marrow cells and PBMCs of
malnourished mice directly ex vivo. We and others have
shown that increased arginase activity is associated with the
severity of a variety of infectious diseases [20,21,23,45,46].
A B
C D
Figure 5 Impact of malnutrition on parasite replication and arginase activity in Leishmania infantum-infected BALB/c mice. Groups of
BALB/c (n =5) mice were fed with a low protein diet (=malnourished (MN) group, 0.7% protein) or normal diet (=control group, 14.4% protein)
and 7 days later, were infected with L. infantum. After nine days, parasite load (A) and arginase activity were measured in the spleens (B). BMMΦ
were activated with IL-4, IFN-γ and TNF-α or left unactivated (nil) and were infected with L. infantum for 4 days and parasite replication (C) and
arginase activity (D) were determined as described in material and methods. Data show the results of one representative experiment out of two
independent experiments. *: p <0.05. nd = not detectable.
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impact on the severity of disease:
i) Increased catabolism of L-arginine by arginase results in
the depletion of L-arginine from the microenvironment;
since L-arginine is essential for efficient T cell activation, this
decrease in L-arginine results in impaired T cell responses
[17,18,47,48]. In an experimental model of leishmaniasis, we
have recently shown that increased arginase activity causes
local depletion of L-arginine, which impairs the capacity of T
cells in the lesion to proliferate and to produce interferon-γ
[30]. Healing, induced by chemotherapy, resulted in control
of arginase activity and reversal of local immunosuppression;
competitive inhibition of arginase as well as supplementation
with L-arginine restored T cell effector functions and re-
duced pathology and parasite growth at the site of lesions
[30]. Indeed, our results also show that the levels of L-
arginine are lower in MN mice. L-arginine is derived from 1)
turnover of cellular protein; 2) from endogenous synthesis:by de novo synthesis from citrulline; and 3) the diet via pro-
tein, which contained from 3-15% of L-arginine [14,15]. It is
therefore likely that insufficient level of protein in the diet re-
sult in reduced levels of L-arginine in plasma [49-51]. Conse-
quently, both PEM and increased levels of arginase might
contribute to the lower level of L-arginine.
PEM malnutrition not only results in lower levels of
L-arginine, it also results in severe alteration of the levels
of different amino acid [49-51]. It is likely that these
changes impact on macrophage effector functions; for
example, glutamine deprivation impacts on antigen
presentation, HLA-DR expression and cytotoxic effect of
TNF-α of macrophages [52]. Furthermore, increased intra-
cellular levels of arginase-induced L-arginine catabolites
such as ornithine, putrescine, spermine and spermidine
can downregulate macrophage [53-55]. Of note, we have
previously shown that in vitro, L-arginine deprivation did
not impact on arginase activity and NO production [56].
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mote the growth of Leishmania parasites directly via the
polyamine synthesis in macrophages [26]: arginase hydroly-
ses L-arginine to urea and ornithine; the latter is the main
intracellular source for the synthesis of polyamines, which
are necessary for parasite growth. Inhibition of arginase in
activated BMMΦ clearly reduced parasite replication [26].
Indeed, our results show that BMMΦ derived from MN
mice express significantly more arginase and provide a
more permissive environment for Leishmania replication.
Furthermore, the increased parasite burden in the
spleen of MN BALB/c mice infected with L. infantum
coincides with increased arginase activity.
To the best of our knowledge, this is the first study that
shows that PEM results in increased arginase activity in
monocytes and macrophages, however the mechanisms
responsible for this upregulation of arginase have not been
identified yet. Upregulation of arginase has been extensively
described in murine macrophages: cytokines such as IL-4
and IL-13, which can synergize with IL-10 and IL-21, as
well as IL-6, induce the expression of arginase; in addition,
lipospolysaccharide and lipoprotein, as well as inflamma-
tory stimuli such as thioglycollate, carrageenan and casein
can also induce arginase [13]. Therefore, it is tempting to
speculate that upregulation of arginase is induced as a
result of PEM-induced inflammation. Whereas arginase
upregulation in macrophages during PEM is STAT6- or
TLRs- dependent remains to be established [57].
Conclusion
Our results show that macrophages and monocytes from
malnourished mice express significantly more arginase
both in vitro and in vivo. We proposed that increased
arginase-mediated L-arginine catabolism is a mechanism
likely to contribute to more severe disease by promoting
parasite growth. Further work into the impact of arginase-
mediated L-arginine catabolism during PEM is warranted
as this may result in the identification of novel therapeutic
dietary interventions that might interfere with this path-
way and therefore improve immune responses and resist-
ance to infectious diseases.
Additional files
Additional file 1: High protein diet.
Additional file 2: Low protein diet.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KC, VY, CM, HE and SS performed experiments and analyzed data. SH, PB,
MMo, MMu and IM analysed data. PK designed the research, performed
experiments, analyzed data and wrote the manuscript. All authors read and
approved the final manuscript.Acknowledgments
This work was supported by funds received from The Wellcome Trust
(089201/Z/09/Z, PK and KC). We thank Drs. F. Tacchini-Cottier and B. Griffin
for helpful discussions and critical reading of the manuscript.
Author details
1Department of Medicine, Section of Immunology, Faculty of Medicine,
Imperial College London, Norfolk Place, London W2 1PG, UK. 2Immunology
and Infection Department, London School of Hygiene and Tropical Medicine,
London, UK. 3Department of Biochemistry, WHO Immunology Research and
Training Center, University of Lausanne, Lausanne, Switzerland. 4School of
Biological Sciences, Royal Holloway, University of London, Egham, UK.
5International AIDS Vaccine Initiative Human Immunology Laboratory, Faculty
of Medicine, Imperial College London, London, UK. 6Department of Cellular
Immunology, Max-Planck-Institute for Immunobiology and Epigenetics,
Freiburg, Germany. 7Third Department of Medicine (Hematology, Oncology,
and Pneumology), University Medical Center Mainz, Mainz, Germany.
Received: 20 May 2014 Accepted: 24 September 2014
Published: 24 October 2014
References
1. Katona P, Katona-Apte J: The interaction between nutrition and infection.
Clin Infect Dis 2008, 46:1582–1588.
2. Bhutta ZA, Salam RA: Global nutrition epidemiology and trends. Ann Nutr
Metab 2012, 61(Suppl 1):19–27.
3. Beisel WR: Nutrition in pediatric HIV infection: setting the research agenda.
Nutrition and immune function: overview. J Nutr 1996, 126:2611S–2615S.
4. Schaible UE, Kaufmann SH: Malnutrition and infection: complex
mechanisms and global impacts. PLoS Med 2007, 4:e115.
5. Woodward B: Protein, calories, and immune defenses. Nutr Rev 1998,
56:S84–S92.
6. Chandra RK: Nutrition and immunity in the elderly. Nutr Res Rev 1991,
4:83–95.
7. Najera O, Gonzalez C, Toledo G, Lopez L, Cortes E, Betancourt M, Ortiz R:
CD45RA and CD45RO isoforms in infected malnourished and infected
well-nourished children. Clin Exp Immunol 2001, 126:461–465.
8. Rodriguez L, Gonzalez C, Flores L, Jimenez-Zamudio L, Graniel J, Ortiz R:
Assessment by flow cytometry of cytokine production in malnourished
children. Clin Diagn Lab Immunol 2005, 12:502–507.
9. Redmond HP, Leon P, Lieberman MD, Hofmann K, Shou J, Reynolds JV,
Goldfine J, Johnston RB Jr, Daly JM: Impaired macrophage function in
severe protein-energy malnutrition. Arch Surg 1991, 126:192–196.
10. de la Fuente M, Munoz ML: Impairment of phagocytic process in
macrophages from young and old mice by protein malnutrition. Ann
Nutr Metab 1992, 36:41–47.
11. Schaffer MR, Tantry U, Ahrendt GM, Wasserkrug HL, Barbul A: Acute
protein-calorie malnutrition impairs wound healing: a possible role of
decreased wound nitric oxide synthesis. J Am Coll Surg 1997, 184:37–43.
12. Fock RA, Rogero MM, Vinolo MA, Curi R, Borges MC, Borelli P: Effects of
protein-energy malnutrition on NF-kappaB signalling in murine
peritoneal macrophages. Inflammation 2010, 33:101–109.
13. Munder M: Arginase: an emerging key player in the mammalian immune
system. Br J Pharmacol 2009, 158:638–651.
14. Morris SM Jr: Recent advances in arginine metabolism: roles and regulation
of the arginases. Br J Pharmacol 2009, 157:922–930.
15. Morris SM Jr: Arginases and arginine deficiency syndromes. Curr Opin Clin
Nutr Metab Care 2012, 15:64–70.
16. Nagaraj S, Gabrilovich DI: Myeloid-derived suppressor cells in human
cancer. Cancer J 2010, 16:348–353.
17. Bronte V, Zanovello P: Regulation of immune responses by L-arginine
metabolism. Nat Rev Immunol 2005, 5:641–654.
18. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC: Arginase, prostaglandins,
and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer
Res 2007, 13:721s–726s.
19. Morris SM Jr: Recent advances in arginine metabolism. Curr Opin Clin Nutr
Metab Care 2004, 7:45–51.
20. Cloke T, Garvery L, Choi BS, Abebe T, Hailu A, Hancock M, Kadolsky U,
Bangham CRM, Munder M, Müller I, Taylor GP, Kropf P: Increased arginase
activity correlates with disease severity in HIV seropositive patients.
J Infect Dis 2010, 202:374–385.
Corware et al. Nutrition & Metabolism 2014, 11:51 Page 10 of 10
http://www.nutritionandmetabolism.com/content/11/1/5121. Takele Y, Abebe T, Weldegebreal T, Hailu A, Hailu W, Ali J, Diro E, Sisay Y,
Cloke T, Modolell M, Munder M, Müller I, Kropf P: Arginase activity in the
blood of patients with visceral leishmaniasis and HIV infection. PLoS NTD
2012, 7:e1977.
22. Abebe T, Takele T, Weldegebreal T, Cloke T, Closs E, Corset C, Hailu A, Hailu
W, Sisay Y, Corware K, Modolell M, Munder M, Tacchini-Cottier F, Müller I,
Kropf P: Arginase: a marker of disease status in patients with visceral
leishmaniasis. PLoS NTD 2013, 7:e2134.
23. Abebe T, Hailu A, Woldeyes M, Mekonene W, Bilch K, Cloke T, Fry L, al
Basatena N-K S, Corware K, Modolell M, Munder M, Tacchini-Cottier F, Müller
I, Kropf P: Local increase of arginase activity in lesions of patients with
cutaneous leishmaniasis in Ethiopia. PLoS NTD 2012, 6:e1684.
24. Malafaia G: Protein-energy malnutrition as a risk factor for visceral
leishmaniasis: a review. Parasite Immunol 2009, 31:587–596.
25. Han JM, Levings MK: Immune regulation in obesity-associated adipose
inflammation. J Immunol 2013, 191:527–532.
26. Kropf P, Fuentes JM, Fahnrich E, Arpa L, Herath S, Weber V, Soler G, Celada
A, Modolell M, Muller I: Arginase and polyamine synthesis are key factors
in the regulation of experimental leishmaniasis in vivo. Faseb J 2005,
19:1000–1002.
27. Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, Fuentes JM,
Luckner C, Doschko G, Soler G, Eichmann K, Müller FM, Ho AD, Goerner M,
Modolell M: Arginase I is constitutively expressed in human granulocytes
and participates in fungicidal activity. Blood 2005, 105:2549–2556.
28. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M:
Th1/Th2-regulated expression of arginase isoforms in murine
macrophages and dendritic cells. J Immunol 1999, 163:3771–3777.
29. Kropf P, Baud D, Marshall SE, Munder M, Mosley A, Fuentes JM, Bangham
CR, Taylor GP, Herath S, Choi BS, Soler G, Teoh T, Modolell M, Muller I:
Arginase activity mediates reversible T cell hyporesponsiveness in human
pregnancy. Eur J Immunol 2007, 37:935–945.
30. Modolell M, Choi B-S, Ryan RO, Hancock M, Titus RG, Abebe T, Hailu A,
Müller I, Rogers M, Bangham CRB, Munder M, Kropf P: Local suppression of
T cell responses by arginase-induced L-arginine depletion in nonhealing
leishmaniasis. PLoS Negl Trop Dis 2009, 14:e480.
31. Kropf P, Brunson K, Etges R, Müller I: The Leishmaniasis Model. In Immunology
of Infection. Volume 25. 1st edition. San Diego: Academic; 1998:419–458
[Kaufmann SHE, Kabelitz D (Series Editor): Methods in Microbiology].
32. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev
Immunol 2005, 5:953–964.
33. Shi C, Pamer EG: Monocyte recruitment during infection and inflammation.
Nat Rev Immunol 2011, 11:762–774.
34. Morley JE: Undernutrition in older adults. Fam Pract 2012,
29(Suppl 1):i89–i93.
35. Borelli P, Barros FE, Nakajima K, Blatt SL, Beutler B, Pereira J, Tsujita M, Favero
GM, Fock RA: Protein-energy malnutrition halts hemopoietic progenitor
cells in the G0/G1 cell cycle stage, thereby altering cell production rates.
Braz J Med Biol Res 2009, 42:523–530.
36. Mirkovich AM, Galelli A, Allison AC, Modabber FZ: Increased myelopoiesis
during Leishmania major infection in mice: generation of ‘safe targets’, a
possible way to evade the effector immune mechanism. Clin Exp Immunol
1986, 64:1–7.
37. Hoover DL, Nacy CA: Macrophage activation to kill Leishmania tropica:
defective intracellular killing of amastigotes by macrophages elicited
with sterile inflammatory agents. J Immunol 1984, 132:1487–1493.
38. Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, Sigl V,
Hanada T, Hanada R, Lipinski S, Wild B, Camargo SM, Singer D, Richter A,
Kuba K, Fukamizu A, Schreiber S, Clevers H, Verrey F, Rosenstiel P, Penninger
JM: ACE2 links amino acid malnutrition to microbial ecology and
intestinal inflammation. Nature 2012, 487:477–481.
39. Bando JK, Nussbaum JC, Liang HE, Locksley RM: Type 2 innate lymphoid
cells constitutively express arginase-I in the naive and inflamed lung.
J Leukoc Biol 2013, 94:877–884.
40. Teshima S, Rokutan K, Takahashi M, Nikawa T, Kido Y, Kishi K: Alteration of
the respiratory burst and phagocytosis of macrophages under protein
malnutrition. J Nutr Sci Vitaminol (Tokyo) 1995, 41:127–137.
41. Redmond HP, Shou J, Kelly CJ, Leon P, Daly JM: Protein-calorie malnutrition
impairs host defense against Candida albicans. J Surg Res 1991, 50:552–559.
42. Wang C, Yu X, Cao Q, Wang Y, Zheng G, Tan TK, Zhao H, Zhao Y, Harris D:
Characterization of murine macrophages from bone marrow, spleen and
peritoneum. BMC Immunol 2013, 14:6.43. Muller I, Hailu A, Choi BS, Abebe T, Fuentes JM, Munder M, Modolell M,
Kropf P: Age-related alteration of arginase activity impacts on severity of
leishmaniasis. PLoS Negl Trop Dis 2008, 2:e235.
44. Agarwal PK, Agarwal KN, Agarwal DK: Biochemical changes in saliva of
malnourished children. Am J Clin Nutr 1984, 39:181–184.
45. Cloke T, Munder M, Bergin P, Herath S, Modolell M, Taylor GP, Müller I,
Kropf P: Phenotypic alteration of neutrophils in the blood of HIV
seropositive patients. PLoS One 2013, 8:e72034.
46. Zea AH, Culotta KS, Ali J, Mason C, Park HJ, Zabaleta J, Garcia LF, Ochoa AC:
Decreased expression of CD3 zeta and nuclear transcription factor
kappa B in patients with pulmonary tuberculosis: potential mechanisms
and reversibility with treatment. J Infect Dis 2006, 194:1385–1393.
47. Popovic PJ, Zeh HJ 3rd, Ochoa JB: Arginine and immunity. J Nutr 2007,
137:1681S–1686S.
48. Munder M, Choi B-S, Rogers M, Kropf P: L-arginine deprivation impairs
Leishmania major-specific T cell responses. Eur J Immunol 2009,
39:2161–2172.
49. Padilla H, Sanchez A, Powell RN, Umezawa C, Swendseid ME, Prado PM,
Sigala R: Plasma amino acids in children from Guadalajara with kwashiorkor.
Am J Clin Nutr 1971, 24:353–357.
50. Poeze M, Bruins MJ, Luiking YC, Deutz NE: Reduced caloric intake during
endotoxemia reduces arginine availability and metabolism. Am J Clin
Nutr 2010, 91:992–1001.
51. Moyano D, Vilaseca MA, Artuch R, Lambruschini N: Plasma amino acids in
anorexia nervosa. Eur J Clin Nutr 1998, 52:684–689.
52. Roth E: Immune and cell modulation by amino acids. Clin Nutr 2007,
26:535–544.
53. Hasko G, Kuhel DG, Marton A, Nemeth ZH, Deitch EA, Szabo C: Spermine
differentially regulates the production of interleukin-12 p40 and
interleukin-10 and suppresses the release of the T helper 1 cytokine
interferon-gamma. Shock 2000, 14:144–149.
54. Perez-Cano FJ, Franch A, Castellote C, Castell M: Immunomodulatory action
of spermine and spermidine on NR8383 macrophage line in various
culture conditions. Cell Immunol 2003, 226:86–94.
55. Zhang M, Caragine T, Wang H, Cohen PS, Botchkina G, Soda K, Bianchi M,
Ulrich P, Cerami A, Sherry B, Tracey KJ: Spermine inhibits proinflammatory
cytokine synthesis in human mononuclear cells: A counterregulatory
mechanism that restrains the immune response. J Exp Med 1997,
185:1759–1768.
56. Choi BS, Martinez-Falero IC, Corset C, Munder M, Modolell M, Muller I,
Kropf P: Differential impact of L-arginine deprivation on the activation
and effector functions of T cells and macrophages. J Leukoc Biol 2009,
85:268–277.
57. El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M,
Basaraba RJ, Konig T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA,
Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ:
Toll-like receptor-induced arginase 1 in macrophages thwarts effective
immunity against intracellular pathogens. Nat Immunol 2008, 9:1399–1406.
doi:10.1186/1743-7075-11-51
Cite this article as: Corware et al.: Protein energy malnutrition increases
arginase activity in monocytes and macrophages. Nutrition & Metabolism
2014 11:51.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
